The global photodynamic therapy market is anticipated to grow at a CAGR of around 15.5% during the forecast period 2020 to 2027 and to reach around US$ 11.5 Bn by 2027.
Market Dynamics
Increasing number of patients suffering from chronic diseases such as neck and head cancer and introduction of innovative solution from major players are major factors expected to drive the growth of global market. There is high increase in number of patients suffering from cancer in countries such as US, and Europe. According to American Society of Clinical Oncology head and neck cancer accounts for about 4% of all cancers in the US. In 2020, they estimated 65,630 people (48,200 men and 17,430 women) will develop head and neck cancer and 14,500 deaths (10,760 men and 3,740 women).
In addition, increasing government spending on development of present healthcare infrastructure, high R&D activities, coupled with availability of favorable insurance policies are among other factors expected to support the growth of target market. Increasing medical tourism in developing countries and focus on development of hospital infrastructure in order to facilitate the advanced treatment is another factor expected to augment the growth of target market.
Players focus on business development in order to enhance the business presence and customer base are other factors expected to augment the growth of target market.
In 2016, Biofrotera AG a global biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products received FDA approval for two products for Ameluz a topical prescription drug and BF-RhodoLED for PDT in the treatment of mild-to-moderate actinic keratosis.
In 2017 Biofrotera AG AMELUZ gel (10%) and BF-RhodoLED lamp in the U.S. market. this is expected to help the company to strengthen in position in US market.
Favorable business policies by the government and emergence of small and mid-size enterprises are factors influencing the growth of target market. However, factors such as high cost associated to R&D activities and stringent government regulations related to product approval are expected to hamper the growth of global photodynamic therapy market. Rapid technological advancements by major players along with introduction of innovative solutions are factors expected to create new opportunities for players operating in the target market over the forecast period. In addition, inclination towards developing countries in order to enhance the business presence is another factor expected to support the revenue transaction of target market.
Segment Analysis by Region
The market in North America is expected to account for significant revenue share owing to increasing number of patients suffering from chronic diseases. In addition, availability of advanced infrastructure for R&D activities, high investment by major players and introduction of novel solutions are factors expected to support the growth of target market.
Major players inclination towards business expansion through strategic merger & acquisitions in order to increase the customer base will impact to growth of target market.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
|
Market
|
Global Photodynamic Therapy Market
|
|
Analysis Period
|
2016 – 2027
|
|
Base Year
|
2019
|
|
Forecast Data
|
2020 – 2027
|
|
Market Stratification
|
Product, Application, End Use and Geography
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
|
Photodynamic Therapy Market Segment Analysis, 2019
The global photodynamic therapy market is segmented into product, application and end use. The product segment is segmented into drugs and devices. The application segment is further divided into cancer, psoriasis, acne, and others. Among the application, the cancer segment is expected to account for major revenue share due to increasing number of patients suffering from various diseases. In addition, high R&D activities and development of innovative products are factors expected to support the growth of target segment. The end use segment is further bifurcated into hospitals, cosmetics & dermatology clinics, cancer treatment centers, others.
The players profiled in the report are Theralase Technologies Inc., Lumibird, Quest PharmaTech Inc., Modulight, Inc., Galderma Laboratories L.P., Biofrontera AG, Sun Pharmaceutical Industries Ltd., and SUS Advancing Technology Co., Ltd.
Market Segmentation
Market By Product
Drugs
- Porphyrin Derivative (PD)
- Aminolevulinic Acid (ALA)
- Chlorines
- Others
Devices
- Disposable Fiber Optic Light Delivery Devices (DFOLDD)
- Diode Lasers
Market By Application
Cancer
- Basal Cell Carcinoma
- Non-small Cell Lung Cancer
- Head & Neck Cancer
- Others
Actinic Keratosis (AK)
Psoriasis
Acne
Others
Market By End User
Hospitals
Cosmetics & Dermatology Clinics
Cancer Treatment Centers
Others
Market By Region
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Photodynamic Therapy
1.1. Definition and Scope
1.1.1. Definition of Photodynamic Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Photodynamic Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Photodynamic Therapy Market By Product
1.2.3. Photodynamic Therapy Market By Application
1.2.4. Photodynamic Therapy Market By End User
1.2.5. Photodynamic Therapy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Photodynamic Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Photodynamic Therapy Market
3.7. Value Chain Analysis
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Photodynamic Therapy Market By Product
4.1. Introduction
4.2. Photodynamic Therapy Revenue By Product
4.2.1. Photodynamic Therapy Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Drugs
4.2.2.1. Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.2. Porphyrin Derivative (PD)
4.2.2.3. Aminolevulinic Acid (ALA)
4.2.2.4. Chlorines
4.2.2.5. Others
4.2.3. Devices
4.2.3.1. Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.2. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
4.2.3.3. Diode Lasers
CHAPTER 5. Photodynamic Therapy Market Revenue By Application
5.1. Introduction
5.2. Photodynamic Therapy Revenue (US$ Mn) By Application
5.2.1. Photodynamic Therapy Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Cancer
5.2.2.1. Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.2. Basal Cell Carcinoma
5.2.2.3. Non-small Cell Lung Cancer
5.2.2.4. Head & Neck Cancer
5.2.2.5. Others
5.2.3. Actinic Keratosis (AK)
5.2.3.1. Actinic Keratosis (AK) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Psoriasis
5.2.4.1. Psoriasis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Acne
5.2.5.1. Acne Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Others
5.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Photodynamic Therapy Market By End User
6.1. Introduction
6.2. Photodynamic Therapy Revenue (US$ Mn) By End User
6.2.1. Photodynamic Therapy Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Cosmetics & Dermatology Clinics
6.2.3.1. Cosmetics & Dermatology Clinics Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Cancer Treatment Centers
6.2.4.1. Cancer Treatment Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Photodynamic Therapy Market By Country
7.1. North America Photodynamic Therapy Overview
7.2. U.S.
7.2.1. U.S. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Photodynamic Therapy Market By Country
8.1. Europe Photodynamic Therapy Market Overview
8.2. U.K.
8.2.1. U.K. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Photodynamic Therapy Market By Country
9.1. Asia Pacific Photodynamic Therapy Market Overview
9.2. China
9.2.1. China Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3. China Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3. Japan
9.3.1. Japan Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3. Japan Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4. India
9.4.1. India Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3. India Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5. Australia
9.5.1. Australia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3. Australia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3. South Korea Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7.3. Rest of Asia-Pacific Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Photodynamic Therapy Market By Country
10.1. Latin America Photodynamic Therapy Market Overview
10.2. Brazil
10.2.1. Brazil Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. Brazil Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Mexico Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2. Rest of Latin America Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 11. Middle East & Africa Photodynamic Therapy Market By Country
11.1. Middle East & Africa Photodynamic Therapy Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Saudi Arabia Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. UAE
11.3.1. UAE Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. UAE Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
CHAPTER 12. Player Analysis Of Photodynamic Therapy
12.1. Photodynamic Therapy Market Company Share Analysis
12.2. Mergers And Acquisition In Global Photodynamic Therapy Market
CHAPTER 13. Company Profile
13.1. Theralase Technologies Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Theralase Technologies Inc. 2019 Photodynamic Therapy Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Manufacturing Plant Footprint Analysis
13.2. Lumibird
13.3. Quest PharmaTech Inc.
13.4. Modulight, Inc.
13.5. Galderma Laboratories L.P.
13.6. Biofrontera AG
13.7. Sun Pharmaceutical Industries Ltd.
13.8. SUS Advancing Technology Co., Ltd
13.9. Others
![Photodynamic Therapy Market (By Product: Drugs [Porphyrin Derivative (PD), Aminolevulinic Acid (ALA), Chlorines, Others], Devices [Disposable Fiber Optic Light Delivery Devices (DFOLDD), Diode Lasers]; By Application: Cancer [Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer, Others], Actinic Keratosis (AK), Psoriasis, Acne, Others; By End User: Hospitals, Cosmetics & Dermatology Clinics, Cancer Treatment Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027](assets/images/format-png.png "Photodynamic Therapy Market (By Product: Drugs [Porphyrin Derivative (PD), Aminolevulinic Acid (ALA), Chlorines, Others], Devices [Disposable Fiber Optic Light Delivery Devices (DFOLDD), Diode Lasers]; By Application: Cancer [Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer, Others], Actinic Keratosis (AK), Psoriasis, Acne, Others; By End User: Hospitals, Cosmetics & Dermatology Clinics, Cancer Treatment Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027")
